Searched for
AVIGAN
Hantavirus: Britain secures experimental Japanese drug to strengthen responseBritain has received experimental favipiravir from Japan to treat a deadly hantavirus outbreak. The drug is not licensed in the UK and its ...- India's Dr.Reddy's ends study of COVID-19 drug Avigan in KuwaitData from the Kuwait trial, conducted in partnership with United Arab Emirates-based medical alliance Global Response Aid FZCO (GRA), showe...
- Dr Reddy's seeks approval from Health Canada for FavipiravirThe application was filed under Health Canada's "Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relatio...
- Nikkei falls as coronavirus resurgence in Europe hits sentimentAll but two of the 33 sector sub-indexes on the Tokyo exchange traded lower, with real estate, pharmaceuticals and land transport leading t...
- Mounting a fightback: Covid-19 vaccine developers reach last leg of trialsAs US regulators tighten the scrutiny around approvals, companies have announced their intention to put their trial data in public domain f...
- Dr Reddy's launches antiviral drug Avigan in India, to launch remdesivir in SeptemberIndian generic drug maker Dr Reddy's Laboratories on Wednesday announced the launch of antiviral drug Avigan (favipiravir) tablets, current...
- Nikkei edges higher, stops short of erasing pandemic lossThe Nikkei ended 0.17% higher at 23,289.36, briefly hitting a six-month high for two straight sessions, but did not rise enough to close a ...
- Sun Pharma latest to sell COVID-19 drug favipiravir in India, to cost Rs 35 per tabletFavipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in ...
- Trending stocks: Dr. Reddy's Laboratories shares up nearly 1%A total of 9,119 shares changed hands on the counter till 11:07AM (IST).
- Dr Reddy’s partners Fujifilm to launch Avigan for Covid-19 treatmentThe agreement provides for Fujifilm Toyama Chemical, a unit of the Japanese company to grant Dr. Reddy's and Dubai-based Global Response Ai...
- Local Covid drug makers ramp up capacityThis follows companies successfully developing the formulations Favipiravir and Remdesivir, the drugs, which along with dexamethasone have ...
- Raghava Life Sciences in talks with formulators for potential Covid drug FavipiravirFavipiravir, a generic version of Avigan that is used to treat influenza in Japan, is being studied as an experimental drug in treating the...
- Glenmark Pharma to study potential Covid-19 drug combinationThe study will look to enroll 158 hospitalized patients of moderate Covid-19 in India, the company added. Last month, Glenmark said it woul...
- Strides Pharma to conduct trials in India for potential COVID-19 drugThe Bengaluru-based company has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country...
- Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patientsThe Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favipi...
- Glenmark pharma starts clinical trial on antiviral Favipiravir for Covid-19 treatmentThe drug sold under brand name Avigan by Fujifilm Toyama Chemical has demonstrated activity against influenza viruses and has been approved...
- Japanese stocks jump on signs of coronavirus slowdownThe benchmark Nikkei average gained 4.2 per cent to 18,576.30, its highest close in nearly a week, tracking sharp gains in US stock futures.
- Japan shares end flat, down 8% for week on economic jittersNikkei index ended up 0.01 per cent at 17,820.19 in a subdued session that saw shares bounce between gains and losses.
- Gilead’s drug leads global race to find virus treatmentThe update on the trials’ progress came a day after the World Health Organization said that remdesivir may be the only effective treatment ...
- NRI kids row: Grandparents, political leaders protest
Load More
